Viking Global Investors
VBIV

Viking Global Investors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Viking Global Investors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-293,299
Closed -$25.2M – 111
2020
Q3 		$25.2M Buy
+293,299
New +$34.2M 0.09% 79

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Viking Global Investors's VBIV Position: Q4 2020 in Review

Viking Global Investors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 293,299 shares — an estimated $25.2M sold.

Viking Global Investors first reported a position in VBIV in Q3 2020 and held it in 1 quarter. The position peaked at $25.2M in Q3 2020. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

  • Viking Global Investors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
  • Viking Global Investors sold 293,299 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $25.2M.
  • Viking Global Investors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 1 quarter.
  • Viking Global Investors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $25.2M in Q3 2020.
  • 122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Viking Global Investors's 13F filing for Q4 2020, filed 16 Feb 2021.